Middle east respiratory syndrome coronavirus infection mediated by the transmembrane serine protease TMPRSS2

Journal of Virology

Volumn 87, Issue 23, 2013, Pages 12552-12561

  Shirato, Kazuya ^a   Kawase, Miyuki ^a   Matsuyama, Shutoku ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

(23,25) TRANSEPOXYSUCCINYL LEVO LEUCYLAMINDO 3 METHYLBUTANE ETHYL ESTER; CAMOSTAT; CATHEPSIN L; CYSTEINE PROTEINASE; CYSTEINE PROTEINASE INHIBITOR; LEUPEPTIN; MEMBRANE PROTEIN; PEPTIDASE; PROTEIN TMPRSS2; SERINE PROTEINASE; THREONINE PROTEINASE; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN; CELL STRAIN CALU 3; CELL STRAIN MRC 5; CELL STRAIN WI 38; CELL SURFACE; CONTROLLED STUDY; CORONAVIRUS; CORONAVIRUS INFECTION; ENDOSOME; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; INFECTION SENSITIVITY; LUNG ALVEOLUS CELL; MIDDLE EAST RESPIRATORY SYNDROME; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYNCYTIUM; VERO CELL; VIROGENESIS; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS INHIBITION;

ANTIVIRAL AGENTS; CELL LINE; CELL MEMBRANE; CORONAVIRUS; CORONAVIRUS INFECTIONS; GABEXATE; GIANT CELLS; HUMANS; SERINE ENDOPEPTIDASES; SERINE PROTEINASE INHIBITORS; VIRUS INTERNALIZATION;

EID: 84887169848     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01890-13     Document Type: Article

References (27)

1. Zaki AM, Van Boheemen S, Bestebroer TM, Osterhaus ADME, Fouchier RA. 2012. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N. Engl. J. Med. 367:1814-1820.
2. De Groot RJ, Baker SC, Baric RS, Brown CS, Drosten C, Enjuanes L, Fouchier RA, Galiano M, Gorbalenya AE, Memish Z, Perlman S, Poon LL, Snijder EJ, Stephens GM, Woo PC, Zaki AM, Zambon M, Ziebuhr J. 2013. Middle East respiratory syndrome coronavirus (MERS-CoV); announcement of the Coronavirus Study Group. J. Virol. 87:7790-7792.
3. Danielsson N, ECDC Internal Response Team, Catchpole M. 2012. Novel coronavirus associated with severe respiratory disease:case definition and public health measures. Euro Surveill. 17(39):pii-20282. http: //www.eurosurveillance.org/ViewArticle.aspx?ArticleId-20282.
4. Chan JF-W, Chan K-H, Choi GK-Y, To KK-W, Tse H, Cai J-P, Yeung ML, Cheng VC-C, Chen H, Che X-Y, Lau SK-P, Woo PC-Y, Yuen K-Y. 2013. Differential cell line susceptibility to the emerging novel human betacoronavirus 2c EMC/2012:implications for disease pathogenesis and clinical manifestation. J. Infect. Dis. 207:1743-1752.
5. Raj VS, Mou H, Smits SL, Dekkers DH, Müller MA, Dijkman R, Muth D, Demmers JA, Zaki A, Fouchier RA, Thiel V, Drosten C, Rottier PJ, Osterhaus AD, Bosch BJ, Haagmans BL. 2013. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature 495:251-254.
6. Gierer S, Bertram S, Kaup F, Wrensch F, Heurich A, Krämer-Kühl A, Welsch K, Winkler M, Meyer B, Drosten C, Dittmer U, Von Hahn T, Simmons G, Hofmann H, Pöhlmann S. 2013. The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2 and is targeted by neutralizing antibodies. J. Virol. 87:5502-5511.
7. Simmons G, Reeves JD, Rennekamp AJ, Amberg SM, Piefer AJ, Bates P. 2004. Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry. Proc. Natl. Acad. Sci. U.S.A. 101:4240-4245.
8. Matsuyama S, Taguchi F. 2009. Two-step conformational changes in a coronavirus envelope glycoprotein mediated by receptor binding and proteolysis. J. Virol. 83:11133-11141.
9. Bertram S, Heurich A, Lavender H, Gierer S, Danisch S, Perin P, Lucas JM, Nelson PS, Pöhlmann S, Soilleux EJ. 2012. Influenza and SARScoronavirus activating proteases TMPRSS2 and HAT are expressed at multiple sites in human respiratory and gastrointestinal tracts. PLoS One 7:e35876. doi:10.1371/journal.pone.0035876.
10. Shulla A, Heald-Sargent T, Subramanya G, Zhao J, Perlman S, Gallagher T. 2011. A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry. J. Virol. 85:873-882.
11. Bertram S, Glowacka I, Blazejewska P, Soilleux E, Allen P, Danisch S, Steffen I, Choi S-Y, Park Y, Schneider H, Schughart K, Pöhlmann S. 2010. TMPRSS2 and TMPRSS4 facilitate trypsin-independent spread of influenza virus in Caco-2 cells. J. Virol. 84:10016-10025.
12. Bertram S, Glowacka I, Müller MA, Lavender H, Gnirss K, Nehlmeier I, Niemeyer D, He Y, Simmons G, Drosten C, Soilleux EJ, Jahn O, Steffen I, Pöhlmann S. 2011. Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsinlike protease. J. Virol. 85:13363-13372.
13. Bertram S, Glowacka I, Steffen I, Kühl A, Pöhlmann S. 2010. Novel insights into proteolytic cleavage of influenza virus hemagglutinin. Rev. Med. Virol. 20:298-310.
14. Böttcher E, Freuer C, Steinmetzer T, Klenk H-D, Garten W. 2009. MDCK cells that express proteases TMPRSS2 and HAT provide a cell system to propagate influenza viruses in the absence of trypsin and to study cleavage of HA and its inhibition. Vaccine 27:6324-6329.
15. Böttcher E, Matrosovich T, Beyerle M, Klenk H-D, Garten W, Matrosovich M. 2006. Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium. J. Virol. 80: 9896-9898.
16. Böttcher-Friebertshäuser E, Freuer C, Sielaff F, Schmidt S, Eickmann M, Uhlendorff J, Steinmetzer T, Klenk H-D, Garten W. 2010. Cleavage of influenza virus hemagglutinin by airway proteases TMPRSS2 and HAT differs in subcellular localization and susceptibility to protease inhibitors. J. Virol. 84:5605-5614.
17. Chaipan C, Kobasa D, Bertram S, Glowacka I, Steffen I, Tsegaye TS, Takeda M, Bugge TH, Kim S, Park Y, Marzi A, Pöhlmann S. 2009. Proteolytic activation of the 1918 influenza virus hemagglutinin. J. Virol. 83:3200-3211.
18. Choi S-Y, Bertram S, Glowacka I, Park YW, Pöhlmann S. 2009. Type II transmembrane serine proteases in cancer and viral infections. Trends Mol. Med. 15:303-312.
19. Matsuyama S, Nagata N, Shirato K, Kawase M, Takeda M, Taguchi F. 2010. Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2. J. Virol. 84:12658-12664.
20. Shirogane Y, Takeda M, Iwasaki M, Ishiguro N, Takeuchi H, Nakatsu Y, Tahara M, Kikuta H, Yanagi Y. 2008. Efficient multiplication of human metapneumovirus in Vero cells expressing the transmembrane serine protease TMPRSS2. J. Virol. 82:8942-8946.
21. Shirato K, Matsuyama S, Ujike M, Taguchi F. 2011. Role of proteases in the release of porcine epidemic diarrhea virus from infected cells. J. Virol. 85:7872-7880.
22. Kawase M, Shirato K, Van der Hoek L, Taguchi F, Matsuyama S. 2012. Simultaneous treatment of human bronchial epithelial cells with serine and cysteine protease inhibitors prevents severe acute respiratory syndrome coronavirus entry. J. Virol. 86:6537-6545.
23. Matsuyama S, Ujike M, Morikawa S, Tashiro M, Taguchi F. 2005. Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection. Proc. Natl. Acad. Sci. U.S.A. 102:12543-12547.
24. Saharkhiz-Langroodi A, Holland TC. 1997. Identification of the fusionfrom-without determinants of herpes simplex virus type 1 glycoprotein B. Virology 227:153-159.
25. Kawase M, Shirato K, Matsuyama S, Taguchi F. 2009. Proteasemediated entry via the endosome of human coronavirus 229E. J. Virol. 83:712-721.
26. Müller MA, Raj VS, Muth D, Meyer B, Kallies S, Smits SL, Wollny R, Bestebroer TM, Specht S, Suliman T, Zimmermann K, Binger T, Eckerle I, Tschapka M, Zaki AM, Osterhaus AD, Fouchier RA, Haagmans BL, Drosten C. 2012. Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines. mBio 3(6):e00515-12. doi:10 .1128/mBio.00515-12.
27. Yoshikawa T, Hill TE, Yoshikawa N, Popov VL, Galindo CL, Garner HR, Peters CJ, Tseng C-TK. 2010. Dynamic innate immune responses of human bronchial epithelial cells to severe acute respiratory syndromeassociated coronavirus infection. PLoS One 5:e8729. doi:10.1371/journal .pone.0008729.